Mackenzie Financial Corp Has $134.74 Million Position in Intuitive Surgical, Inc. $ISRG

Mackenzie Financial Corp cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.3% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 247,948 shares of the medical equipment provider’s stock after selling 777 shares during the quarter. Mackenzie Financial Corp owned about 0.07% of Intuitive Surgical worth $134,737,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of ISRG. Norges Bank acquired a new position in shares of Intuitive Surgical in the second quarter valued at approximately $2,569,260,000. Nuveen LLC bought a new stake in Intuitive Surgical in the 1st quarter valued at $1,715,899,000. Vanguard Group Inc. boosted its stake in Intuitive Surgical by 2.1% in the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock worth $18,115,025,000 after purchasing an additional 670,302 shares during the period. Goldman Sachs Group Inc. increased its holdings in Intuitive Surgical by 26.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider’s stock worth $1,396,496,000 after purchasing an additional 584,375 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Intuitive Surgical by 20.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock valued at $1,680,922,000 after purchasing an additional 566,979 shares during the period. 83.64% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, EVP Henry L. Charlton sold 13,731 shares of the firm’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $7,963,980.00. Following the completion of the sale, the executive vice president directly owned 3,056 shares of the company’s stock, valued at $1,772,480. This trade represents a 81.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, VP Fredrik Widman sold 2,067 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $550.00, for a total value of $1,136,850.00. Following the transaction, the vice president owned 473 shares of the company’s stock, valued at $260,150. This represents a 81.38% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 86,804 shares of company stock worth $48,043,866 in the last three months. Insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on ISRG shares. Daiwa Capital Markets upped their price objective on Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research report on Friday, October 24th. Jefferies Financial Group upped their price target on Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a research report on Wednesday, October 22nd. The Goldman Sachs Group raised their price target on shares of Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, October 31st. Finally, Sanford C. Bernstein restated an “outperform” rating and set a $685.00 target price on shares of Intuitive Surgical in a report on Tuesday, October 21st. Two research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $608.92.

Intuitive Surgical Trading Down 0.2%

NASDAQ:ISRG opened at $573.32 on Friday. The stock has a market capitalization of $205.52 billion, a PE ratio of 75.84, a P/E/G ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The firm has a fifty day simple moving average of $505.94 and a 200 day simple moving average of $505.05.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter last year, the company posted $1.84 earnings per share. The company’s revenue for the quarter was up 22.9% compared to the same quarter last year. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.